Stage IV NSCLC
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| sugemalimab | EQRx, Inc. (EQRX) |
Frequently asked questions
How many drugs are in development for Stage IV NSCLC?
BioSniper tracks 1 drug in development for Stage IV NSCLC across 1 company.
How many clinical trials target Stage IV NSCLC?
There are 1 clinical trial targeting Stage IV NSCLC tracked by BioSniper.
Deep-dive into Stage IV NSCLC
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis